GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syschem (India) Ltd (BOM:531173) » Definitions » Total Equity

Syschem (India) (BOM:531173) Total Equity : ₹570 Mil (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Syschem (India) Total Equity?

Syschem (India)'s total equity for the quarter that ended in Mar. 2024 was ₹570 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Syschem (India) Total Equity Historical Data

The historical data trend for Syschem (India)'s Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syschem (India) Total Equity Chart

Syschem (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.12 71.24 69.42 223.05 569.56

Syschem (India) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 223.05 - 250.98 - 569.56

Syschem (India) Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Syschem (India)'s Total Equity for the fiscal year that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=1640.281-1070.717
=570

Syschem (India)'s Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=1640.281-1070.717
=570

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syschem (India) Total Equity Related Terms

Thank you for viewing the detailed overview of Syschem (India)'s Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Syschem (India) (BOM:531173) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syschem (India) Ltd (BOM:531173) » Definitions » Total Equity
Comparable Companies
BOM:532878 BOM:524518 BOM:532637 BOM:537536 NSE:VAISHALI BOM:524824 BOM:532384 BOM:530313 NSE:SOTAC BOM:540702 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
S.C.O. 825, 1st Floor, NAC Mani Majra, Chandigarh, PB, IND, 160101
Website
https://www.syschem.in
Syschem (India) Ltd is a company that produces Active Pharmaceutical Ingredients and bulk drugs. It also undertakes contract manufacturing and custom synthesis business. In addition, the company is also involved in the purification of specialty solvents. The products offered by the company include Amoxycillin Tri-Hydrate, Ampicillin Tri-Hydrate, Cloxacillin Cloxacillin Sodium, Dicloxacillin Sodium, Flucloxacillin Sodium, Cephalexin, Cefixime, Cefadroxil, Distillation of Speciality Solvents - DMF, Acetonitrile, Ethyl Acetate, and THF.

Syschem (India) (BOM:531173) Headlines

No Headlines